Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kamran Hosseini, Subba Gollamudi, Harvey Reiser, Tom Walters & Richard L Lindstrom. (2023) 0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects. Clinical Ophthalmology 17, pages 2219-2230.
Read now
Read now
Burcu Üner, Samet Özdemir, Çetin Taş, Yıldız Özsoy & Melike Üner. (2022) Development of lipid nanoparticles for transdermal loteprednol etabonate delivery. Journal of Microencapsulation 39:4, pages 327-340.
Read now
Read now
Articles from other publishers (4)
Burcu Uner, Samet Ozdemir, Cetin Tas, Melike Uner & Yildiz Ozsoy. (2023) Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity. AAPS PharmSciTech 24:4.
Crossref
Crossref
Michael Korenfeld, Joe Gira, Kevin Jong, Joseph Martel, Steven Vold, Tom Walters, Dale Usner & Eric Donnenfeld. (2022) OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study. Clinical Therapeutics 44:12, pages 1577-1587.
Crossref
Crossref
Zora T. Marlowe, Megan E. Cavet & Martin J. Coffey. (2021) Dose Uniformity of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38% Compared with Prednisolone Acetate Ophthalmic Suspension 1%. Ophthalmology and Therapy 11:1, pages 435-441.
Crossref
Crossref
Connie Kang, Susan J. Keam, Matt Shirley & Yahiya Y. Syed. (2020) Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery. Clinical Drug Investigation 40:4, pages 387-394.
Crossref
Crossref